Cole Anthony
ORL
Changed teams this offseason (MIL to ORL). Has been available for roughly 70% of games across recent seasons, which pulls the games projection down.
Value
+-2.32
League Leader10.7
This Player3.5
League Average2.6
Ranking Trend
Lower rank is better.
Full data
| Season | Rank |
|---|---|
| 20-21 | #235 |
| 21-22 | #128 |
| 22-23 | #114 |
| 23-24 | #189 |
| 24-25 | #256 |
| 25-26 | #399 |
| 26-27 Projection | #339 |
Stat Trend
Track role, durability, and category growth by season.
Full data
| Season | PTS |
|---|---|
| 20-21 | 12.9 |
| 21-22 | 16.3 |
| 22-23 | 13 |
| 23-24 | 11.6 |
| 24-25 | 9.4 |
| 25-26 | 6.7 |
| 26-27 Projection | 8.1 |
Within-Season Trend
PTS by month across 25-26 (averages). Useful for spotting injury recovery and rookie/second-year ramps. Change the stat with the selector above.
Fantasy playoffs (final ~3 weeks)
Full data
| Month | PTS |
|---|---|
| Oct 2025 | 13 |
| Nov 2025 | 6.7 |
| Dec 2025 | 2.4 |
| Jan 2026 | 8.7 |
| Feb 2026 | 3 |
Fantasy playoffs run the final ~3 weeks of the season (late March into April); shown approximately at month resolution and dependent on your league's settings. ESPN and Yahoo defaults differ by about a week.
Season History
Compare season stats and fantasy ranks for draft analysis.
| SeasonNBA season | AgeAge during the season | TeamTeam | GPGames played | GSGames started | MPGMinutes per game | RankOverall fantasy rank (averages) | ValueFantasy ranking value (averages) | PTSPoints per game | REBRebounds per game | ASTAssists per game | STLSteals per game | BLKBlocks per game | 3PMThree-pointers made per game | FG%Field goal percentage | FGAField goal attempts per game | FT%Free throw percentage | FTAFree throw attempts per game | TOTurnovers per game |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-27 ProjectionModel Zero | 27 | ORL | 54 | 0 | 16.7 | #339 | -2.32 | 8.1 | 2.8 | 3.1 | 0.6 | 0.4 | 0.8 | 42.6% | 7.3 | 80.2% | 1.3 | 1.7 |
| 25-26 | 26 | MIL | 35 | 0 | 15 | #399 | -4.47 | 6.7 | 2.5 | 3.5 | 0.6 | 0.3 | 0.6 | 42.4% | 6.6 | 61.5% | 0.7 | 1.9 |
| 24-25 | 25 | MEM | 67 | 0 | 18.4 | #256 | -1.46 | 9.4 | 3 | 2.9 | 0.7 | 0.5 | 1.1 | 42.4% | 8.1 | 82.3% | 1.7 | 1.5 |
| 23-24 | 24 | ORL | 81 | 0 | 22.4 | #189 | -0.19 | 11.6 | 3.8 | 2.9 | 0.8 | 0.5 | 1.1 | 43.5% | 9.4 | 82.6% | 2.7 | 1.6 |
| 22-23 | 23 | ORL | 60 | 0 | 25.9 | #114 | 1.97 | 13 | 4.8 | 3.9 | 0.6 | 0.5 | 1.3 | 45.4% | 10.2 | 89.4% | 2.8 | 1.5 |
| 21-22 | 22 | ORL | 65 | 0 | 31.7 | #128 | 1.78 | 16.3 | 5.4 | 5.7 | 0.7 | 0.3 | 2 | 39.1% | 14 | 85.4% | 3.9 | 2.6 |
| 20-21 | 21 | ORL | 47 | 0 | 27.1 | #235 | -1.25 | 12.9 | 4.7 | 4.1 | 0.6 | 0.4 | 1.2 | 39.7% | 11.7 | 83.2% | 2.8 | 2.3 |